These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 22752548)
1. Expression of bone morphogenetic protein-4 in the cortical lesions of focal cortical dysplasia IIb and the tuberous sclerosis complex. Guo W; Zhang CQ; Shu HF; Yang MH; Yin Q; Yang H J Mol Neurosci; 2013 May; 50(1):7-13. PubMed ID: 22752548 [TBL] [Abstract][Full Text] [Related]
2. Activation of leukocyte immunoglobulin-like receptor B2 signaling pathway in cortical lesions of pediatric patients with focal cortical dysplasia type IIb and tuberous sclerosis complex. Yue J; Zhang C; Shi X; Wei Y; Liu L; Liu S; Yang H Brain Dev; 2019 Nov; 41(10):829-838. PubMed ID: 31495513 [TBL] [Abstract][Full Text] [Related]
3. Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia. Talos DM; Sun H; Kosaras B; Joseph A; Folkerth RD; Poduri A; Madsen JR; Black PM; Jensen FE Ann Neurol; 2012 Apr; 71(4):539-51. PubMed ID: 22447678 [TBL] [Abstract][Full Text] [Related]
4. Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers. Boer K; Lucassen PJ; Spliet WG; Vreugdenhil E; van Rijen PC; Troost D; Jansen FE; Aronica E Epilepsia; 2009 Dec; 50(12):2629-37. PubMed ID: 19583781 [TBL] [Abstract][Full Text] [Related]
5. Altered expression of the Plexin-B2 system in tuberous sclerosis complex and focal cortical dysplasia IIb lesions. Dai L; Huang J; Shen KF; Yang XL; Zhu G; Zhang L; Wang ZK; Liu SY; Liao X; Xu SL; Yang H; Li XY; Zhang CQ Histol Histopathol; 2024 Sep; 39(9):1179-1195. PubMed ID: 38293776 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex. Sun FJ; Zhang CQ; Chen X; Wei YJ; Li S; Liu SY; Zang ZL; He JJ; Guo W; Yang H J Neuroinflammation; 2016 Apr; 13(1):85. PubMed ID: 27095555 [TBL] [Abstract][Full Text] [Related]
7. Increased expression of matrix metalloproteinase 9 in cortical lesions from patients with focal cortical dysplasia type IIb and tuberous sclerosis complex. Li S; Yu S; Zhang C; Shu H; Liu S; An N; Yang M; Yin Q; Yang H Brain Res; 2012 May; 1453():46-55. PubMed ID: 22459050 [TBL] [Abstract][Full Text] [Related]
8. Expression of TRPV1 in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb. Shu HF; Yu SX; Zhang CQ; Liu SY; Wu KF; Zang ZL; Yang H; Zhou SW; Yin Q Brain Dev; 2013 Mar; 35(3):252-60. PubMed ID: 22647236 [TBL] [Abstract][Full Text] [Related]
9. [Expression of autophagy-related proteins in malformations of cortical development]. Chen S; Piao Y; Fu Y; Li Z; Liu C; Lu D Zhonghua Bing Li Xue Za Zhi; 2015 May; 44(5):305-9. PubMed ID: 26178210 [TBL] [Abstract][Full Text] [Related]
10. Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers. Toering ST; Boer K; de Groot M; Troost D; Heimans JJ; Spliet WG; van Rijen PC; Jansen FE; Gorter JA; Reijneveld JC; Aronica E Epilepsia; 2009 Jun; 50(6):1409-18. PubMed ID: 19220410 [TBL] [Abstract][Full Text] [Related]
11. Cellular localization of metabotropic glutamate receptors in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex. Boer K; Troost D; Timmermans W; Gorter JA; Spliet WG; Nellist M; Jansen F; Aronica E Neuroscience; 2008 Sep; 156(1):203-15. PubMed ID: 18706978 [TBL] [Abstract][Full Text] [Related]
12. Expression and cellular distribution of FGF13 in cortical tubers of the tuberous sclerosis complex. Wu K; Yue J; Shen K; He J; Zhu G; Liu S; Yang H; Zhang CQ Neurosci Lett; 2021 Apr; 749():135714. PubMed ID: 33582188 [TBL] [Abstract][Full Text] [Related]
13. Elevated Expression of TRPC4 in Cortical Lesions of Focal Cortical Dysplasia II and Tuberous Sclerosis Complex. Wang LK; Chen X; Zhang CQ; Liang C; Wei YJ; Yue J; Liu SY; Yang H J Mol Neurosci; 2017 Jun; 62(2):222-231. PubMed ID: 28455787 [TBL] [Abstract][Full Text] [Related]
15. Expression of the Nogo-A system in cortical lesions of pediatric patients with tuberous sclerosis complex and focal cortical dysplasia type IIb. Yu SX; Li S; Shu HF; Zhang CQ; Liu SY; Yang H J Neuropathol Exp Neurol; 2012 Jul; 71(7):665-77. PubMed ID: 22710967 [TBL] [Abstract][Full Text] [Related]
16. Oxidative stress and inflammation in a spectrum of epileptogenic cortical malformations: molecular insights into their interdependence. Arena A; Zimmer TS; van Scheppingen J; Korotkov A; Anink JJ; Mühlebner A; Jansen FE; van Hecke W; Spliet WG; van Rijen PC; Vezzani A; Baayen JC; Idema S; Iyer AM; Perluigi M; Mills JD; van Vliet EA; Aronica E Brain Pathol; 2019 May; 29(3):351-365. PubMed ID: 30303592 [TBL] [Abstract][Full Text] [Related]
17. Down-regulated expression of acid-sensing ion channel 1a in cortical lesions of patients with focal cortical dysplasia. Guo W; Chen X; He JJ; Wei YJ; Zang ZL; Liu SY; Yang H; Zhang CQ J Mol Neurosci; 2014 Jun; 53(2):176-82. PubMed ID: 24682892 [TBL] [Abstract][Full Text] [Related]
18. Expression patterns of glial fibrillary acidic protein (GFAP)-delta in epilepsy-associated lesional pathologies. Martinian L; Boer K; Middeldorp J; Hol EM; Sisodiya SM; Squier W; Aronica E; Thom M Neuropathol Appl Neurobiol; 2009 Aug; 35(4):394-405. PubMed ID: 19508443 [TBL] [Abstract][Full Text] [Related]
19. Downregulated formyl peptide receptor 2 expression in the epileptogenic foci of patients with focal cortical dysplasia type IIb and tuberous sclerosis complex. Huang K; Wang Z; He Z; Li Y; Li S; Shen K; Zhu G; Liu Z; Lv S; Zhang C; Yang H; Yang X; Liu S Immun Inflamm Dis; 2022 Nov; 10(11):e706. PubMed ID: 36301030 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of fibroblast growth factor (FGF)-2 in epilepsy-associated malformations of cortical development (MCDs). Sugiura C; Miyata H; Ueda M; Ohama E; Vinters HV; Ohno K Neuropathology; 2008 Aug; 28(4):372-81. PubMed ID: 18179408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]